Diagnostic Challenges and Treatment Impact in Vitiligo Management
November 11th 2024Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying disease subtypes and distinguishing vitiligo from other depigmentation disorders.
Watch
Describing Intrauterine Induction and Target Patient Populations
November 8th 2024The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild male factor infertility or cervical factor infertility, while emphasizing the importance of careful patient selection, timing of the procedure and monitoring for potential complications.
Watch
Background of Assisted Reproductive Technology
November 8th 2024Kenan R. Omurtag, M.D., discusses how assisted reproductive technology encompasses various medical procedures like in vitro fertilization, intracytoplasmic sperm injection and gamete donation to help individuals or couples struggling with infertility achieve pregnancy through manipulation of eggs, sperm or embryos outside the body.
Watch
Future Modalities for Infertility
November 1st 2024Lucy van de Wiel, PhD, discusses how emerging technologies such as in vitro gametogenesis and gene editing show promise for addressing complex infertility cases, potentially revolutionizing reproductive medicine by offering new solutions for patients with genetic disorders, same-sex couples, and those with uterine factor infertility.
Watch
Lucy van de Wiel, PhD, discusses how in vitro fertilization (IVF) has evolved since its first successful use in 1978, initially targeting women with blocked fallopian tubes but expanding to address various fertility issues, including male factor infertility, unexplained infertility and genetic disorders, while also becoming more accessible to diverse patient populations including same-sex couples and single individuals.
Watch
Impact of Infertility on Partners
November 1st 2024Lucy van de Wiel, PhD, discusses how infertility can strain relationships between partners by causing emotional distress, communication breakdowns, sexual difficulties and feelings of blame or inadequacy, potentially leading to conflicts and decreased relationship satisfaction.
Watch
Association of Infertility and Mental Health
October 25th 2024Lucy van de Wiel, PhD, discusses how infertility often leads to psychological distress and depression in patients, with stress potentially exacerbating fertility issues and creating a challenging cycle that can negatively impact conception efforts.
Watch
Key Clinical Information on Infertility
October 25th 2024Lucy van de Wiel, PhD, discusses how infertility is defined as the inability to conceive after 12 months of regular unprotected intercourse, diagnosed through medical history, physical exams and tests, with risk factors including age, lifestyle habits and medical conditions.
Watch
Optimizing the Management of TRD
Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.
Watch
Payer Strategies to Reduce Delay to TRD Therapy
Dr Martin Rosenzweig discusses the importance of data collection to improve patient care in TRD as well as alternative payment models.
Watch
Clinician Friendly Information Needed on Diseases Emerging Because of Climate Change | ID Week 2024
October 21st 2024University of Washington’s Peter Rabinowitz, M.D., M.P.H., sees a world awash in emerging diseases and climate change data but says it needs to be delivered to clinicians in a form that they can use at the point of care, possibly via the electronic medical record.
Watch
How Race Was Defined in the ELEVATUM Study | AAO 2024
October 19th 2024Patients self-identified as members of the minority group that the study was designed to enroll, according to Jeremiah Brown, M.D., of Retina Consultants of Texas, one of the lead ELEVATUM investigators. The study will yield a "treasure trove" of data, Brown said.
Watch
ELEVATUM Study's Reason to Be: Underrepresentation in Clinical Trials | AAO 2024
October 19th 2024Enrollment goals for the U.S. part of the phase 4, open-label study of Vabysmo (faricimab) were 45% Black participants, 45% Hispanic participants and 10% Native American, Pacific Islander and Native Hawaiian, said Jeremiah Brown, M.D., a lead ELEVATUM investigator.
Watch
Real-World Evidence of Apretude Highlights High Adherence, Effectiveness as PrEP | ID Week 2024
October 19th 2024Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted results of two real-world evidence studies of Apretude as an HIV prevention medication.
Watch
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
October 18th 2024Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years later according to Prime Therapeutics’ real-world evidence, says Ben Urick, Pharm.D., Ph.D., a health outcomes researcher for the pharmacy benefit manager.
Watch
The Role of Quality, Benchmarking and KPIs in ART Decision-Making
October 18th 2024Jeffrey Dunn, Pharm.D., MBA, discusses how quality measures, benchmarking and key performance indicators play a crucial role in their daily work by guiding decision-making, improving patient outcomes and ensuring the continuous enhancement of fertility treatment and assisted reproductive technology (ART) program effectiveness.
Watch
Integrated Policymaking and Measuring Patient Outcomes in TRD
Drs Martin Rosenzweig and Samuel Nordberg share perspectives for integrated policymaking in behavioral health, as well as payer and provider collaboration for TRD.
Watch
Navigating Payer Policies for Alternative Therapies in TRD
Carrie Jardine leads a discussion on varying prior authorization policies for alternative therapies for TRD along with implications to patients.
Watch
Benefit Design and Overcoming Barriers to Access for Alternative Therapies in TRD
Carrie Jardine and Martin Rosenzweig, MD, share considerations for benefit design in behavioral health.
Watch
Alternative Treatment Options for TRD
Dr Patricia Ares-Romero and Dr Martin Rosenzweig discuss treatment strategies for TRD, including alternative therapies and explain current barriers within the healthcare system that inhibit access.
Watch
Best Practices in Communicating the Benefits of ART
October 11th 2024A medical expert in infertility discusses how best practices in communicating benefits for fertility treatments and assisted reproductive technology (ART) programs involve clear, concise and accessible information delivery and tailoring messages to diverse patient populations to ensure comprehensive understanding of coverage options and treatment processes.
Watch
Incorporating Social Determinants of Health in ART
October 11th 2024Jeffrey Dunn, Pharm.D., MBA, discusses how social determinants of health and population health factors are integrated into decision-making processes for fertility treatments and assisted reproductive technology (ART) programs to ensure equitable access and improve overall outcomes across diverse patient populations.
Watch
Jeffrey Dunn, Pharm.D., MBA, discusses how the overall issues for assisted reproductive technologies (ARTs) encompass a range of challenges, including access, affordability, efficacy and ethical considerations, and the need for continued research and improvement in treatment protocols
Watch